MARK SHEPTOFF FINANCIAL PLANNING, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARK SHEPTOFF FINANCIAL PLANNING, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q2 2020$34,000
+47.8%
2000.0%0.02%
+29.4%
Q1 2020$23,0000.0%2000.0%0.02%
+21.4%
Q4 2019$23,000
+35.3%
2000.0%0.01%
+27.3%
Q3 2019$17,000
+21.4%
2000.0%0.01%
+10.0%
Q2 2019$14,000
-6.7%
2000.0%0.01%
-9.1%
Q1 2019$15,000
+36.4%
2000.0%0.01%
+22.2%
Q4 2018$11,000
-26.7%
2000.0%0.01%
-10.0%
Q3 2018$15,000
+15.4%
2000.0%0.01%0.0%
Q2 2018$13,000
+30.0%
2000.0%0.01%
+42.9%
Q1 2018$10,000
-9.1%
2000.0%0.01%0.0%
Q4 2017$11,0000.0%2000.0%0.01%0.0%
Q3 2017$11,000
+10.0%
2000.0%0.01%0.0%
Q2 2017$10,000
-23.1%
200
-0.5%
0.01%
-22.2%
Q1 2017$13,000
+18.2%
201
+0.5%
0.01%
+12.5%
Q4 2016$11,0000.0%2000.0%0.01%0.0%
Q3 2016$11,000
+37.5%
2000.0%0.01%
+33.3%
Q2 2016$8,000
+14.3%
2000.0%0.01%0.0%
Q1 2016$7,000
-22.2%
2000.0%0.01%
-14.3%
Q4 2015$9,000
+12.5%
2000.0%0.01%0.0%
Q3 2015$8,000
-20.0%
2000.0%0.01%
-12.5%
Q2 2015$10,000
-37.5%
200
-55.6%
0.01%
-38.5%
Q1 2015$16,000
+14.3%
4500.0%0.01%
+8.3%
Q4 2014$14,000
-17.6%
4500.0%0.01%
-20.0%
Q3 2014$17,0000.0%4500.0%0.02%0.0%
Q2 2014$17,000
-19.0%
4500.0%0.02%
-21.1%
Q1 2014$21,0004500.02%
Other shareholders
SEATTLE GENETICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders